This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove Behavioural Health Remove Drugs Remove Marketing Related Topics
Pharma Production Reagent Gene Therapy FDA Approval Clinical Research Gene Development Clinical Trials Medicine Trials More Related Topics >
article thumbnail

Changing Faces: pharma supplier, DTx, and non-profit hires from November 2022

pharmaphorum

DECEMBER 16, 2022

Digital therapeutics company Cognoa, which focuses on paediatric behavioural health, announced the appointment of Dr Sharief Taraman as its new CEO. Generative AI drug creation company Absci Corporation has added Dan Rabinovitsj (as pictured), VP of connectivity at Meta, to its Board of Directors. Digital therapeutics hires.

Behavioural Health 52
Behavioural Health Reagent Gene Therapy Production 52
article thumbnail

Orexo eyes opioid use disorder app launch before year-end

pharmaphorum

OCTOBER 2, 2020

“Modia is designed to close the gap as it relates to the access and receipt of quality, evidence-based therapeutic interventions and behavioural health services for individuals with OUD who participate in outpatient treatment with MAT,” said Michael Sumner, Orexo’s chief medical officer.

Behavioural Health 98
Behavioural Health Production FDA Approval Pharma Production 98
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 32,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024